INTS4L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Comparison | Statistical significance |
Normal-vs-Primary | 4.848400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.644800E-01 |
Normal-vs-Stage2 |
5.619400E-01 |
Normal-vs-Stage3 |
2.520200E-01 |
Normal-vs-Stage4 |
2.441800E-02 |
Stage1-vs-Stage2 |
4.387000E-01 |
Stage1-vs-Stage3 |
1.637190E-01 |
Stage1-vs-Stage4 |
3.142000E-03 |
Stage2-vs-Stage3 |
1.387800E-01 |
Stage2-vs-Stage4 |
2.516200E-02 |
Stage3-vs-Stage4 |
2.613600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.611800E-01 |
Normal-vs-AfricanAmerican |
8.511200E-01 |
Normal-vs-Asian |
5.446400E-01 |
Caucasian-vs-AfricanAmerican |
6.796400E-01 |
Caucasian-vs-Asian |
7.391200E-01 |
AfricanAmerican-vs-Asian |
6.593200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.623400E-01 |
Normal-vs-Female |
5.972800E-01 |
Male-vs-Female |
7.515400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.399700E-02 |
Normal-vs-Age(41-60Yrs) |
9.810000E-01 |
Normal-vs-Age(61-80Yrs) |
3.644800E-01 |
Normal-vs-Age(81-100Yrs) |
1.731170E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.639600E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.263230E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.239200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.053200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.753430E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.833400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.786200E-02 |
Normal-vs-Grade 2 |
6.977600E-01 |
Normal-vs-Grade 3 |
2.363000E-01 |
Normal-vs-Grade 4 |
2.036100E-03 |
Grade 1-vs-Grade 2 |
1.378400E-01 |
Grade 1-vs-Grade 3 |
1.414200E-02 |
Grade 1-vs-Grade 4 |
4.45079999999987E-05 |
Grade 2-vs-Grade 3 |
3.215800E-02 |
Grade 2-vs-Grade 4 |
4.64440000003119E-06 |
Grade 3-vs-Grade 4 |
7.955200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.473600E-01 |
Normal-vs-ccB subtype |
6.925600E-02 |
ccA subtype-vs-ccB subtype |
6.821900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.481600E-01 |
Normal-vs-N1 |
2.115800E-01 |
N0-vs-N1 |
3.754600E-01 |
|
|